AI Summary & Key Takeaways
AI InsightThe high inci-dence of myelofibrosis in Hodgkin's disease suggests that Hodgkin's disease must be investigated for early diagnosis and therapy in the case of idiopathic myelofibrosis.
📌 3 Key Takeaways
Abstract
The importance of bone marrow biopsy in Hodgkin's disease is well known. The incidence of bone marrow involvement in Hodgkin's disease varies from 2% to 29%. The presence of myelofibrosis is not suffirent evidence for a definitive diagnosis of bone marrow involvement. Patients having myelofibrosis as a first symptom without peripheral lympadenopathy must be distin-guished from patients with idiopathic myelofibrosis. In this study, we examined the frequency of bone marrow involvement and the degree of myelofibrosis in Hodgkin's dis-ease. We found the incidence of bone marrow involvement to be 5.26%, and that of myelofibrosis to be 31.6%. The high inci-dence of myelofibrosis in Hodgkin's disease suggests that Hodgkin's disease must be investigated for early diagnosis and therapy in the case of idiopathic myelofibrosis.